Daito Pharmaceutical Co (TSE:4577) Other Net Income (Loss) : 円2 Mil (TTM As of Feb. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Other Net Income (Loss)?

Daito Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Feb. 2024 was 円0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 was 円2 Mil.

Daito Pharmaceutical Co's quarterly Other Net Income (Loss) increased from Aug. 2023 (円0 Mil) to Nov. 2023 (円1 Mil) but then declined from Nov. 2023 (円1 Mil) to Feb. 2024 (円0 Mil).

Daito Pharmaceutical Co's annual Other Net Income (Loss) stayed the same from May. 2021 (円0 Mil) to May. 2022 (円0 Mil) but then increased from May. 2022 (円0 Mil) to May. 2023 (円1 Mil).

Daito Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Daito Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Other Net Income (Loss) Chart

Daito Pharmaceutical Co Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Other Net Income (Loss)

Get a 7-Day Free Trial

1.00

Daito Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Net Income (Loss)	Get a 7-Day Free Trial															-1.00	1.00	-	1.00	-

Daito Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2 Mil.

Daito Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co (TSE:4577) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines